sarizotan Newron drops development of sarizotan in Rett syndrome By www.pharmatimes.com Published On :: Tue, 05 May 2020 11:09:35 +0100 The experimental 5-HT1A receptor agonist and D2 receptor antagonist was not effective on primary or secondary endpoints Full Article
sarizotan Newron ditches sarizotan program after pivotal trial flop, sees shares crater By www.fiercebiotech.com Published On :: Mon, 04 May 2020 07:54:54 +0000 Newron will terminate work on its experimental Rett syndrome drug sarizotan after a complete failure in its pivotal STARS trial. Full Article
